This product is not intended to diagnose, treat, cure, or prevent any disease. These statements have not been evaluated by the Food and Drug Administration.
This information is for educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment. Always consult your healthcare provider before using herbs, especially if you are pregnant, nursing, taking medications, or have a medical condition.
BM
MetabolicAI-summarized
Berberine Metabolic
Berberis aristata
Blood sugar management in Asian traditional medicine
PubMed · The effects of <i>Berberis vulgaris</i> L. and <i>Berberis aristata</i> L. in metabolic syndrome patients: a systematic and meta-analysis study. (2023)
PubMed · Berberis aristata DC. (Indian barberry): Current insight into botanical, phytochemical, and pharmacological aspects, pharmacokinetics, safety of use and modern therapeutic applications. (2025)
Reviewed by: HerbAlly Editorial Team, Medical herbalists and healthcare professionals
This sheet was compiled from PubMed (NIH) abstracts using AI assistance. Every factual claim is cited to a real PubMed article (see the source list). It has not yet been human-reviewed — confirm with a healthcare provider before use.
Compiled from 30 PubMed articles · model: gemma4:31b
Summary
Berberis aristata (Indian barberry) is a medicinal shrub containing the primary bioactive alkaloid berberine, used to manage metabolic syndrome, diabetes, and various inflammatory conditions [PMID:40239774, PMID:33040642].
Background
Berberis aristata DC., also known as Indian barberry, Daruharidra, or tree turmeric, is a member of the Berberidaceae family native to the Indian Peninsula [PMID:40239774, PMID:22808523]. It is a shrub characterized by yellow flowers and red or purple berries [PMID:40239774].
Traditional uses
Traditionally used in Ayurveda and Middle Eastern medicine to treat liver and pancreatic disorders, skin infections, diabetes, conjunctival inflammation, jaundice, malaria, typhoid fever, diarrhea, wound healing, and gynecological disorders [PMID:40239774, PMID:34757887, PMID:22808523, PMID:24991073].
Active compounds
The primary phytochemicals are isoquinoline alkaloids, specifically berberine, which is found in the roots, rhizomes, and stem bark [PMID:40239774, PMID:10767672].
Mechanism of action
Berberine exerts anti-inflammatory and antioxidant activities [PMID:27671811]. It acts via the Nrf2 signaling pathway to preserve redox balance [PMID:31609017] and modulates immune cells, including T lymphocyte subsets and dendritic cells [PMID:38477663]. It also inhibits tyrosinase through mixed-type inhibition of monophenolase activity [PMID:26212353] and targets efflux and denitrification machinery in certain pathogens [PMID:42127231].
Clinical evidence
Evidence AMetabolic Syndrome
B. aristata treatment significantly lowered LDL, total cholesterol, triglycerides, and glucose levels, while increasing HDL [PMID:33040642].
Evidence ADyslipidaemia
A fixed combination of B. aristata and Silybum marianum (Berberol) was found to be effective in reducing serum lipid levels compared to placebo [PMID:31784970, PMID:23971720].
Evidence BType 2 Diabetes
Berberine is used to improve glucidic and lipidic profiles; a combination with Silybum marianum was evaluated for glycemic clinical advantages [PMID:24277991].
Evidence BType 1 Diabetes
Combination therapy with Silybum marianum led to a reduction in total insulin consumption and decreased glycated hemoglobin compared to placebo [PMID:26384091].
Safety & adverse effects
Berberine is generally recognized as a nutraceutical, though recent calls for data by EFSA emphasize the need for more comprehensive safety assessments of commercial extracts [PMID:39275269].
Drug interactions
Berberine absorption is limited by P-glycoprotein (P-gp) in enterocytes; P-gp antagonists like silymarin may influence its bioavailability [PMID:24277991, PMID:15039293].
Evidence summary
Strong evidence (Meta-analyses and RCTs) supports the use of B. aristata and its alkaloid berberine for lipid-lowering and glucose-regulating effects in metabolic syndrome and diabetes. Other pharmacological activities (anti-cancer, anti-inflammatory, antimicrobial) are supported primarily by review articles and in vitro/animal models.
PubMed sources
1.PMID: 27671811 (2016) — Berberine and Its Role in Chronic Disease. · Advances in experimental medicine and biology
2.PMID: 10767672 (2000) — Berberine. · Alternative medicine review : a journal of clinical therapeutic
3.PMID: 40239774 (2025) — Berberis aristata DC. (Indian barberry): Current insight into botanical, phytochemical, and pharmacological aspects, pharmacokinetics, safety of use and modern therapeutic applications. · Fitoterapia
4.PMID: 33040642 (2023) — The effects of Berberis vulgaris L. and Berberis aristata L. in metabolic syndrome patients: a systematic and meta-analysis study. · Archives of physiology and biochemistry
No direct government monograph is available for this herb. The content below is AI-generated and has not been verified against an authoritative government source. Use the search links to check official sources before relying on this information.
— Berberine: A novel therapeutic strategy for cancer.
· IUBMB life
6.PMID: 34757887 (2022) — Tree Turmeric: A Super Food and Contemporary Nutraceutical of 21st Century - A Laconic Review. · Journal of the American Nutrition Association
7.PMID: 32564751 (2020) — Berberine Administration in Treatment of Colitis: A Review. · Current drug targets
8.PMID: 24277991 (2013) — Preliminary study about the possible glycemic clinical advantage in using a fixed combination of Berberis aristata and Silybum marianum standardized extracts versus only Berberis aristata in patients with type 2 diabetes. · Clinical pharmacology : advances and applications
9.PMID: 22808523 (2012) — Phyto-chemical and pharmacological applications of Berberis aristata. · Fitoterapia
10.PMID: 24152839 (2013) — Effects of Berberis aristata/Silybum marianum association on metabolic parameters and adipocytokines in overweight dyslipidemic patients. · Journal of biological regulators and homeostatic agents
11.PMID: 38094017 (2023) — Antioxidant and antiarthritic potential of berberine: In vitro and in vivo studies. · Chinese herbal medicines
12.PMID: 38477663 (2024) — Berberine: A natural modulator of immune cells in multiple sclerosis. · Immunity, inflammation and disease
13.PMID: 36824006 (2023) — Evaluation of Wound Healing Potential of Root Bark Extract of Berberis aristata and Molecular Docking Analysis of Berberis Phytoconstituents. · Current drug discovery technologies
14.PMID: 31609017 (2020) — Therapeutic and biological activities of berberine: The involvement of Nrf2 signaling pathway. · Journal of cellular biochemistry
15.PMID: 39091899 (2024) — Berberine HCl and diacerein loaded dual delivery transferosomes: Formulation and optimization using Box-Behnken design. · ADMET & DMPK
16.PMID: 23971720 (2013) — Berberis aristata/Silybum marianum fixed combination on lipid profile and insulin secretion in dyslipidemic patients. · Expert opinion on biological therapy
17.PMID: 17583443 (2007) — Antimicrobial activities of Indian Berberis species. · Fitoterapia
18.PMID: 15039293 (2004) — Hepatobiliary excretion of berberine. · Drug metabolism and disposition: the biological fate of chemicals
19.PMID: 26212353 (2016) — Tyrosinase inhibition kinetic studies of standardized extract of Berberis aristata. · Natural product research
20.PMID: 42127231 (2026) — Berberine Attenuates Chromobacterium violaceum's Virulence by Targeting Efflux and Denitrification Machinery. · Chemistry & biodiversity
21.PMID: 26384091 (2016) — The role of a fixed Berberis aristata/Silybum marianum combination in the treatment of type 1 diabetes mellitus. · Clinical nutrition (Edinburgh, Scotland)
22.PMID: 29142419 (2017) — Antipsoriatic and Anti-inflammatory Studies of Berberis aristata Extract Loaded Nanovesicular Gels. · Pharmacognosy magazine
23.PMID: 39272566 (2024) — Proximate Analysis and Techno-Functional Properties of Berberis aristata Root Powder: Implications for Food Industry Applications. · Foods (Basel, Switzerland)
24.PMID: 31784970 (2020) — The Effects of a Fixed Combination of Berberis aristata and Silybum marianum on Dyslipidaemia - A Meta-analysis and Systematic Review. · Planta medica
25.PMID: 35579124 (2022) — Berberis aristata DC Extract Counteracts the High Fat Diet-Induced Reproductive Toxicity in Female Wistar Rats via Modulating Oxidative Stress and Resistance to Leptin and Insulin. · Endocrine, metabolic & immune disorders drug targets
26.PMID: 24991073 (2013) — Detailed pharmacognostical studies on Berberis aristata DC plant. · Ancient science of life
27.PMID: 40868202 (2025) — Effects of Novel Nutraceutical Combination on Lipid Pattern of Subjects with Sub-Optimal Blood Cholesterol Levels. · Biomedicines
28.PMID: 39275269 (2024) — Comprehensive Analysis of Berberis aristata DC. Bark Extracts: In Vitro and In Silico Evaluation of Bioaccessibility and Safety. · Nutrients
29.PMID: 30289011 (2020) — Quality Control Standardization and Evaluation of Antimicrobial Potential of Daruhaldi (Berberis aristata DC) Stem Bark. · Journal of dietary supplements
30.PMID: 22556968 (1983) — IDENTIFICATION OF DARU-HARIDRA: (Coscinium fenestratum). · Ancient science of life